Chromoblastomycosis (CBM) is an implantation mycosis characterized by the presence of pigmented muriform cells in tissue. CBM is endemic in Taiwan, but only three formal cases have been reported to date because of underreporting. To describe and update its epidemiologic features, we report a series of 30 cases between 2003 and 2016 at a single medical center. Patients were predominately male (2.75:1). The mean age of onset was 65.9 years, and disease duration ranged from 2 months to 20 years. Diabetes was the most common comorbidity, and extremities were the most frequent sites of involvement. The lesions presented as papuloplaque, verrucous, cicatricial, targetoid, or mixed types. The dermoscopic features were variable, including red dots, white vague areas, black globules, and sand-like patterns. Among 10 Fonsecaea isolates further identified by sequencing the ITS regions of ribosomal DNA, nine were F. monophora and one was F. nubica. All but one patient received either systemic antifungal agents, surgical excision, or both. Surgical excision achieved a higher complete remission rate than the other forms of treatment did.
Introduction
Chromoblastomycosis (CBM) is an uncommon implantation fungal infection caused by dematiaceous fungi in tropical and subtropical regions. 1 It is prevalent in Madagas-most common. 18 Exophiala, [19] [20] [21] Phialophora, [22] [23] [24] and Rhinocladiella [25] [26] [27] [28] genera have also been associated with CBM. These fungi can be isolated from soil and plant debris. 29 Infections are usually initiated through traumatic inoculation into the human body, particularly in the extremities. 30 The diagnostic characteristic is the presence of brown muriform cells in the infected tissue, 30 which differs from the pigmented hyphae in phaeohyphomycosis. Recently, molecular phylogeny has facilitated the identification of cryptic species within the F. pedrosoi species complex. The formerly known F. compacta is now considered a variant of F. pedrosoi. 31 The isolates identified as F.
pedrosoi morphologically now belong to F. pedrosoi sensu strico, F. monophora, 31 and F. nubica. 32 Based on this new classification, F. monphora is the most prevalent pathogen of CBM in Japan 33 and southern China. 9, 10, 34 Several new species are found in the genus Fonsecaea in recent years, including F. multimorphosa, 35 F. minima, 36 F. erecta, F.
brasiliensis, and F. pugnacious. 37 The last species is a novel pathogen of disseminated CBM with central nervous system involvement. Data on the prevalence of CBM in Taiwan are unavailable because of underreporting and the absence of a nationwide registry system. Only three case reports [38] [39] [40] 
Methods
Thirty patients who between January 2003 and March 2016 received a diagnosis of CBM based on a skin biopsy at Chang Gung Memorial Hospital (Linkou Branch) were enrolled for the analysis. Patient demographics, including sex, age, and occupation, as well as clinical data, such as comorbidities, traumatic history, duration of the lesions, clinical type of skin lesions, microscopic findings of skin specimens, pathogens, treatment, and outcomes, were collected. In addition to morphological identification, 10 available isolates were subjected to molecular identification.
DNA extraction, amplification, and sequencing
After growth on potato dextrose agar, fungal mycelia were collected and placed in a plastic vial, and 0.13 g of metal beads and 800 µl of lysis buffer were added to the vial. The vial was then transferred to the tissue fracture machine (Mini-BeadBeater, BioSpec, the Netherlands) to break down the fungal cell wall. Buffer fluid containing fungal fragments was treated with the components of a DNA extraction kit. The genomic DNA was obtained using a Smart was used to illustrate the sequence differences between the isolates and the type strain of F. monophora.
Statistical analysis
Statistical analyses were performed using SPSS version 21.0 for Windows (IBM, Armonk, N.Y.). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regression. Potentially favorable factors were further analyzed using a multiple logistic regression model. Two-sided P values of <.05 were considered statistically significant.
Result
The clinical findings of all 30 patients are listed in the supplemental data. The age ranged from 29 to 90 years (mean 65.9 ± 13.6). The male to female ratio was 2.75:1. Diabetes was the most common comorbidity. Ten patients (33.3%) had diabetes, which all of them controlled through medication. Three patients had thyroid disorders, but no autoantibodies were detected. No other autoimmune diseases were recorded except for one patient with rheumatoid arthritis. Furthermore, three patients had underlying malignancies, namely, renal cell carcinoma, prostate carcinoma, and colon adenocarcinoma. None of the patients received steroid or immunosuppressive treatments at the time of diagnosis. Seven patients (23.3%) reported a trauma history. The duration of CBM ranged from 2 months to 20 years, but most of the patients suffered from the infection for more than 1 year (70%). Although, every part of the body can be infected, infection of the extremities was most common (73.3%). Rare lesions on the earlobe or face were easily misdiagnosed. Unilateral lesions are common, but three of our cases presented with bilateral satellite lesions. The verrucous (43.3%) type of lesion was the most common clinical presentation. However, several types of lesions were included in our report; for instance, papule, plaque, cicatricial, and mixed-type lesions were noted. Apart from commonly recognized lesions, our study is the first to report targetoid lesions (Fig. 1L ). The targetoid lesion had three zones composed of a central papule, a clear zone, and an elevated border.
Typical lesions can be easily identified through clinical morphologies. Thus, dermoscopy might be a useful tool in our clinics. The lesions revealed the characteristic features of CBM, including white vague areas, red dots, black globules, and sand-like patterns (Fig. 2) . Skin scrapings treated with 20% KOH from the black dot areas revealed muriform cells with or without germinated hyphae (Fig. 3) . However, early and atypical lesions could mimic other diseases. Psoriasis, squamous cell carcinoma, and eczema were the most common differential diagnoses among these cases. However, their pathological features are relatively distinct. CBM is characterized by pseudocarcinomatous hyperplasia, intraepidermal abscesses, muriform cells, and suppurative granulomas.
Pathogens were isolated from 19 cases. All pathogens were identified as F. pedrosoi based on their morphological characters. Ten isolates were available for molecular identification (Table 1) . Based on the sequences of the ITS1-5.8S-ITS2 region of rDNA, nine were reidentified as F. monophora and one as F. nubica. All F. monophora isolates had a sequence identity of 98% or 99% to the type strain of F. monophora CBS 269.37 (Fig. 4) . Four genotypes were noted among them, and the nucleotide differences between genotypes A, B, C, D, and E, and the type strain were 5, 6, 12, 13, and 11, respectively. Figure 5 illustrates the single nucleotide pleomorphisms among the genotypes. The only F. nubica isolate CGMHD 0745 had a 99% identity to the type strain of F. nubica CBS 269.64 in the 568 compared nucleotides. No F. pedrosoi was found in this study.
The most common choice of systemic antifungal agent in our practice was itraconazole 200 mg per day. Terbinafine was the alternative agent. Liquid nitrogen, hot packing, and KI solution were adjuvant therapies for resistant lesions. One patient was treated with only a topical agent (Butenafine cream 1%) because of impaired organ function. Fourteen cases involved a single systemic antifungal agent, either itraconazole or terbinafine. Two patients underwent only surgical excision. In six cases, total excision was performed before or after oral medication was administered. In the other cases, the treatment was various combination regimens. The rate of complete remission was 33.3% (10/30) in our study. Table 2 lists the characteristics and favorable factors of the enrolled patients. The patients with complete remission tended to have few underlying diseases. The cured patients were significantly younger than those with partial remission (odds ratio [OR]: 0.924; 95% CI: 0.859-0.994; P = .034). In addition, the patients with complete remission had higher rates of receiving excisional surgery (OR: 44.333; 95% CI: 3.929-500.269; P = .002). Furthermore, multivariate regression analysis demonstrated that surgical excision was an independent favorable factor for complete remission. 
Discussion
Our patients were older than those reported in studies conducted in Brazil 2 and Madagascar. 4 The difference might be attributable to differences in economic structures among these countries. Currently, young people in Taiwan typically do not earn their livelihood by farming; therefore, they are at a low risk of exposure to soil and plants. By contrast, some older people still continue with their rural occupations, such as farming or gardening, after retirement. The distribution of lesion sites reemphasizes that traumatic inoculation is the primary mode of infection in CBM. The incidence of diabetes mellitus was higher (33.3%) in our patients than in the general population of Taiwan (8%). 44 Impaired chemotaxis function in patients with diabetes mellitus might make them prone to infection. However, most patients investigated in this study were immunocompetent. Three of them had malignancies, but none of them were undergoing chemotherapy or target therapy at the time of our study. None of the patients-including the one with rheumatoid arthritis-received long-term immunosuppressants or systemic steroids for underlying diseases.
In previous reports, 7, 15, 16, 17 clinical manifestations of CBM have been classified into eight types. Our series describes an additional form, targetoid lesions, which are noted for the first time. The central red papule is surrounded by an elevated erythematous border with a pale transitional zone. However, the clinical pattern did not affect the response to treatment, except for the cicatricial one. Although distal extremities are prone to infection because these are common sites of trauma and subsequent inoculation of fungal pathogens, infection of some unusual locations has been noted in previous reports, including the face, 45, 46 auricle, 47 axilla, 48 breast, 49 and the nose. 50 Facial infection is uncommon. We noted two cases in this series, one involving a patient with a lesion on her left cheek (case 28, Fig. 1B ) and another with a patient with a lesion on his right ear (case 30, Fig. 1A ).
The lesions usually run a chronic and protracted course when left untreated. Dermoscopy and skin scraping are useful diagnostic tools in difficult cases. White vague areas, red dots, black globules, and sand-like patterns are the salient features of CBM lesions. The white vague areas correspond to hyperkeratosis of the epidermis and pseudoepitheliomatous hyperplasia in histopathology. The red dots may represent congested vessels. Black globules and sand-like patterns are the foci of muriform cells, associated germinating hyphae, and thrombotic vessels.
CBM is diagnosed according to the presence of muriform cells in the involved tissue. Muriform cells are 5-12 µm in diameter and are round, brown, thick-walled structures with both horizontal and vertical septa. They are considered a fungal element arrested between the yeast and hyphal forms. 30 Nonetheless, germinating hyphae can sometimes be seen to arise from these muriform cells. In a review by Queiroz-Telles et al., 17 such findings were present in their microscopic figures. In the current study, microscopy showed muriform cells with or without germinating hyphae in the lesion scales of seven out of nine patients (Fig. 3) . Prominent pigmented hyphae may lead to a diagnosis of phaeohyphomycosis, but the absence of characteristic muriform cells helps to differentiate it from CBM. Thus, muriform cells are the key feature of CBM, regardless of the presence of hyphae.
The occurrence of squamous cell carcinoma is one of the most distressing conditions. Previous reviews 51, 52 have reported that the risk of malignant transformation depends on the disease duration, severity of the destruction, and vegetating lesions. However, squamous cell carcinoma formation was not recorded in our cases, even in the lesion that was over 20 years old. The pathophysiology of squamous cell carcinomas arising from CBM lesions is not well known. Some hypotheses focus on the chronic inflammatory environment that leads to the production of ROS and nitrogen species as well as enhances COX-2 expression.
51,53
Fonsecaea spp. are among the most common pathogens of CBM worldwide, 54 including several cases reported from Africa, 2,55 Latin American, 4-7 South Asia, [11] [12] [13] [14] Australia, 56, 57 and Europe. 58, 59 The species identification in early reports relied mainly on the morphological characters of fungal isolates, and most Fonsecaea isolates were identified as F. pedrosoi. Because of the new species concept in this genus based on molecular phylogeny analysis, the species can be accurately identified using molecular methods. Through this approach, the true epidemiology of Fonsecaea spp. in CBM in East Asia was revealed. Gomes et al. 60 reported that F. pedrosoi was prevalent with 80% of the total set of strains in Brazil. Yaguchi et al. 33 reidentified 33 isolates previously identified morphologically as F. pedrosoi in Japan and found that all clinical isolates are monophyletic and belong to the lineage of F. monophora. Subsequently, Mitomo et al. 61 reported two case of F. monophora identified using molecular phylogenetic analysis. From southern China, Lu et al. 9 , Xi et al. 10 , and Fransisca et al. 34 also concluded that F. monophora is the most common species. In 2011, Najafzadeh et al. 54 concluded that F. pedrosoi was found nearly exclusively in Central and South America, whereas F. monophora and F. nubica have a worldwide distribution. The strains available for molecular identification in the present study were isolated between 2014 and 2016. The isolates before 2014 were not preserved. Based on current species concept of genus Fonsecaea, F. monophora is the dominant pathogen in CBM cases in Taiwan. Whether the dominance of F. monophora in CBM cases in Taiwan resulted from a change of pathogen epidemiology or from the change in species concept is unknown. Long-term surveillance and molecular identification at the species level for all Fonsecaea isolates from CBM cases is necessary. The F. monophora isolates in this study exhibited high genetic diversity. Five ITS1-5.8S-ITS2 genotypes were observed in nine F. monophora strains isolated from patients living in northern Taiwan. The genotypes C-E exhibited the highest deviation from the type strain but still had a 98% identity to it. F. nubica is a genetic sibling of F. monophora that has been reported in South America, Europe, and Africa. 10, 32, 54 Fransisca et al. 34 presented the first large sample of F. nubica. According to the limited data, except for molecular differences, F. nubica and F. monphora are similar in clinical presentation and treatment response. Reports of skin infections caused by F. nubica in Japan have been published. 62 The first case in Taiwan was also recorded in our study, but it was a purely cutaneous infection on the cheek. Dermoscopy is used to diagnose many skin disorders, mainly for pigmented and vascular lesions. The characteristic dermoscopic features of CBM are rarely mentioned. Red dots, white vague areas, black globules, and sand-like patterns are the four major features. It also reflects the microscopic findings. Red dots represent the dilated and tortured vessel similar to the symptoms of psoriasis in papillary dermis. The white vague areas correspond to the hyperkeatosis of the epidermis and pseudocarcinomatous hyperplasia. The black globules indicate thrombotic vessels. The sandlike pattern consisting of fine brown dots could be the manifestation of muriform cells with germinated hyphae. These typical features may facilitate diagnosing difficult cases over rare locations.
The treatment of CBM is quite challenging. According to previous reports, 15, [63] [64] [65] [66] many modalities, including antifungals, immunomodulatory therapy, physical methods, photodynamic therapy, and surgical excision, have been used for the treatment of CBM. Itraconazole is the most common choice of first-line agents. We defined complete response as no clinical residual lesions, partial response as a decrease in the size or number of lesions, and no response as persistence or an increase in the number and size of lesions. The complete response rate was 33.3% (10/30) in our study. Among the 10 patients with a complete response, two cases involved patients who underwent surgical excision alone and five cases involved patients who underwent antifungal agent either before or after the excision for at least 3 months. These lesions were all of the papule and plaque types, with variable durations. The wounds were reconstructed without skin grafts or flaps. In the remaining three cases, the patients were cured using systemic agents. In two cases, patients underwent monotherapy of itraconazole (200 mg/d) for 4 months (case 20) and 12 months (case 21). The final case had a large verrucous plaque over the left cheek (case 28), which was cured with itraconazole (200 mg/d) for 4 months with an adjuvant topical agent. However, we cannot conclude any specific features from these cases. Except for three cases without a response and four cases that were lost to follow-up before the results were recorded, the patients in most cases exhibited a partial response to the therapy. Itraconazole (200 mg/day) was the most common choice of first-line agent in our practice. However, the second line and combination regimens were variable and depended on the personal experiences of the physicians. Many cases had residual lesions after long-term antifungal treatment. The pathological images of re-biopsy of the refractory lesions showed significant fibrosis, which may prohibit the penetration of medication. Finally, patients could not adhere to the treatment regimen and were lost of follow-up. This might be the reason why the complete response rate was low in our study. Based on our experience, a single lesion that has a well-demarcated border and can be reconstructed without a skin graft or flap is a favorable candidate for surgical excision. Our statistical analysis in Table 2 demonstrates that young age and excisional surgery are two factors associated with favorable outcomes (P < .05). However, due to the small sample size, the results should be interpreted carefully.
In conclusion, we reviewed 30 cases pathologically diagnosed as CBM. Unlike the typical manifestations of CBM, the targetoid pattern is unique. Infections of the ear lobe, cheek, and areola are rare and are easily misdiagnosed. We also presented typical dermoscopic features, such as red dots, white vague areas, black globules, and sand-like patterns. F. monophora was identified as the major pathogen in Taiwan. This might reemphasize the importance of molecular analysis in Fonsecaea spp. We also have the first case of a patient infected by F. nubica in Taiwan.
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